VIVSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
VivoSim Labs, INC.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.16+0.00 (+0.38%)
Close on Oct 19, 2026
- Market cap
- $825.22K
- P/E (TTM)
- –
- Dividend yield
- –
VivoSim Labs statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | VivoSim Labs | Industry median |
|---|---|---|
| Market Cap | $503.10K | $166.30M |
| Enterprise Value | -$1.17M | $88.19M |
| PS Ratio | 4.49 | 3.65 |
Enterprise value
| Measure | VivoSim Labs | Industry median |
|---|---|---|
| EV / Sales | -10.42 | 2.51 |
Income (trailing twelve months)
| Measure | VivoSim Labs | Industry median |
|---|---|---|
| Revenue | $112.00K | $58.34M |
| Operating Income | -$11.33M | -$21.40M |
| Net Income | -$12.34M | -$22.46M |
| EBITDA | -$11.14M | -$16.91M |
| EPS (Diluted) | -$4.45 | -$0.83 |
Margins
| Measure | VivoSim Labs | Industry median |
|---|---|---|
| Operating Margin | -10117.0% | -44.0% |
| Profit Margin | -11016.1% | -40.2% |
| EBITDA Margin | -9943.8% | -30.2% |
| FCF Margin | -9038.4% | -9.27% |
Returns
| Measure | VivoSim Labs | Industry median |
|---|---|---|
| Return on Equity (ROE) | -343.1% | -53.2% |
| Return on Assets (ROA) | -155.9% | -40.9% |
| Return on Capital Employed (ROCE) | -579.9% | -38.1% |
Growth
| Measure | VivoSim Labs | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -21.1% | 5.96% |
| Revenue Growth (3Y CAGR) | -29.3% | 2.25% |
Balance sheet
| Measure | VivoSim Labs | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $1.67M | $61.43M |
| Net Cash (Debt) | $1.67M | $15.35M |
| Net Cash Per Share | $0.52 | $0.66 |
| Equity (Book Value) | -$2.35M | $49.09M |
| Book Value Per Share | -$0.73 | $1.37 |
| Tangible Book Value | -$2.35M | $23.52M |
| Working Capital | $1.33M | $76.81M |
Financial position
| Measure | VivoSim Labs | Industry median |
|---|---|---|
| Current Ratio | 1.70 | 3.34 |
| Quick Ratio | 0.90 | 2.44 |
| Interest Coverage | -944.25 | -6.26 |
Cash flow (trailing twelve months)
| Measure | VivoSim Labs | Industry median |
|---|---|---|
| Operating Cash Flow | -$10.10M | -$12.35M |
| Capital Expenditures | -$23.00K | -$1.08M |
| Free Cash Flow | -$10.12M | -$20.22M |
| FCF Per Share | -$3.17 | -$0.42 |
Efficiency
| Measure | VivoSim Labs | Industry median |
|---|---|---|
| Asset Turnover | 0.01 | 0.39 |
| Revenue Per Employee | $7.47K | $404.87K |
| Profits Per Employee | -$822.53K | -$703.34K |
| Employee Count | 15 | 74 |
Dividends and yields
| Measure | VivoSim Labs | Industry median |
|---|---|---|
| Earnings Yield | -2452.4% | -23.3% |
| FCF Yield | -2012.1% | -8.72% |
| Buyback Yield | -595.7% | -0.59% |
| Shareholder Yield | -595.7% | 0.00% |
Shares
| Measure | VivoSim Labs | Industry median |
|---|---|---|
| Shares Outstanding | 3,194,300 | 58,127,000 |
| Shares Change (YoY) | 83.5% | 10.9% |
| Shares Change (QoQ) | 10.4% | 0.54% |
| Shares Held by Institutions | 3.23% | 59.4% |
Taxes
| Measure | VivoSim Labs | Industry median |
|---|---|---|
| Income Tax | $5.00K | $79.87K |
Scores
| Measure | VivoSim Labs | Industry median |
|---|---|---|
| Altman Z-Score | -139.27 | -0.22 |
| Piotroski F-Score | 2 | 4 |
| Beneish M-Score | -4.72 | -2.62 |
Calculated by StockData from VivoSim Labs's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.